|
gptkbp:instance_of
|
gptkb:Biology
|
|
gptkbp:antigen
|
gptkb:ESAT-6
CFP-10
|
|
gptkbp:body_shape
|
rod-shaped
|
|
gptkbp:cause
|
tuberculosis
|
|
gptkbp:community_health
|
yes
|
|
gptkbp:community_impact
|
millions of deaths annually
|
|
gptkbp:cultivation
|
gptkb:Lowenstein-Jensen_medium
gptkb:Middlebrook_7_H10
|
|
gptkbp:death
|
high in developing countries
|
|
gptkbp:diagnosis
|
blood test
nucleic acid amplification tests
chest X-ray
sputum smear microscopy
skin test
|
|
gptkbp:discovered_by
|
gptkb:Robert_Koch
|
|
gptkbp:disease_resistance
|
gptkb:isoniazid
gptkb:rifampicin
|
|
gptkbp:diseases
|
gptkb:HIV
gptkb:humans
high
|
|
gptkbp:duration
|
6 to 9 months
|
|
gptkbp:epidemiology
|
global health issue
|
|
gptkbp:family
|
gptkb:Mycobacteriaceae
|
|
gptkbp:first_sequenced
|
gptkb:1998
|
|
gptkbp:genus
|
gptkb:Mycobacterium
|
|
gptkbp:has_features
|
positive
|
|
gptkbp:house
|
mycolic acids
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Mycobacterium tuberculosis
|
|
gptkbp:infected_population
|
1.7 billion people
|
|
gptkbp:is_vulnerable_to
|
BCG vaccine
|
|
gptkbp:metabolism
|
slow-growing
|
|
gptkbp:prevention
|
mask wearing
ventilation
screening high-risk groups
|
|
gptkbp:provides_guidance_on
|
gptkb:DOTS
|
|
gptkbp:related_species
|
gptkb:Mycobacterium_africanum
gptkb:Mycobacterium_bovis
|
|
gptkbp:research_areas
|
epidemiological studies
genomic studies
vaccine efficacy
|
|
gptkbp:research_focus
|
vaccine development
host-pathogen interactions
drug resistance mechanisms
|
|
gptkbp:scientific_classification
|
prokaryote
|
|
gptkbp:seed_dispersal
|
4.4 million base pairs
|
|
gptkbp:symptoms
|
weight loss
cough
fever
chronic
night sweats
|
|
gptkbp:transmission
|
airborne droplets
|
|
gptkbp:treatment
|
antibiotics
drug interactions
adherence to therapy
side effects of drugs
|
|
gptkbp:water_requirement
|
aerobic
|
|
gptkbp:water_resistance
|
multi-drug resistant strains
|
|
gptkbp:bfsParent
|
gptkb:Robert_Koch
|
|
gptkbp:bfsLayer
|
4
|